Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about TERT: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
Telomerase Reverse Transcriptase - catalytic subunit of telomerase with roles in cellular senescence, mitochondrial function, and neurodegeneration
No AI portrait yet
| Gene Symbol | TERT |
| Full Name | Telomerase Reverse Transcriptase |
| Chromosome | 5p15.33 |
| Function | dyskerin (DKC1): Stabilizes the complex |
| Primary Expression | hippocampal subgranular zone (SGZ) |
| Molecular Weight | 127 kDa |
| Amino Acids | 1132 aa |
| Exons | 16 |
| Pathways | Telomere Dysfunction |
| UniProt ID | [O14748](https://www.uniprot.org/uniprot/O14748) |
| Ensembl ID | ENSG00000164362 |
| OMIM | 607409 |
| GeneCards | TERT |
| Human Protein Atlas | TERT |
| Reverse transcriptase activity | Catalyzes addition of TTAGGG repeats to telomeres |
| Associated Diseases | AD, ALI, Als, AMI, cancer |
| Known Drugs/Compounds | TAC |
| Interactions | ACVR2A, AGING, AKT, AKT3, AMPK, AND |
| KG Connections | 529 knowledge graph edges |
| Databases | GeneCardsNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
TERT["TERT"] -->|"Promotes"| telomere_synthesis["telomere synthesis"]
TERT["TERT"] -->|"Prevents"| cellular_senescence["cellular senescence"]
TERT["TERT"] -->|"Modulates"| aging["aging"]
TERT["TERT"] -->|"Therapeutic Target"| Cancer["Cancer"]
TERT["TERT"] -->|"Therapeutic Target"| Carcinoma["Carcinoma"]
TERT["TERT"] -->|"Therapeutic Target"| Ms["Ms"]
TERT["TERT"] -->|"Therapeutic Target"| Als["Als"]
TERT["TERT"] -->|"Biomarker For"| Neurodegeneration["Neurodegeneration"]
TAC["TAC"] -->|"Activates"| TERT["TERT"]
MEK_ERK_AP_1["MEK/ERK/AP-1"] -->|"Regulates"| TERT["TERT"]
IDH1["IDH1"] -->|"Therapeutic Target"| TERT["TERT"]
VEGFA["VEGFA"] -->|"Therapeutic Target"| TERT["TERT"]
MDM4["MDM4"] -->|"Therapeutic Target"| TERT["TERT"]
style TERT fill:#8d4900,color:#e0e0e0
style telomere_synthesis fill:#1b5e20,color:#e0e0e0
style cellular_senescence fill:#1b5e20,color:#e0e0e0
style aging fill:#1b5e20,color:#e0e0e0
style Cancer fill:#b71c1c,color:#e0e0e0
style Carcinoma fill:#b71c1c,color:#e0e0e0
style Ms fill:#b71c1c,color:#e0e0e0
style Als fill:#b71c1c,color:#e0e0e0
style Neurodegeneration fill:#b71c1c,color:#e0e0e0
style TAC fill:#00838f,color:#e0e0e0
style MEK_ERK_AP_1 fill:#9C27B0,color:#e0e0e0
style IDH1 fill:#8d4900,color:#e0e0e0
style VEGFA fill:#8d4900,color:#e0e0e0
style MDM4 fill:#8d4900,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Telomere Dysfunction | causes | mechanism | 0.95 |
| Hepatocellular Carcinoma | biomarker_for | disease | 0.90 |
| Telomere Dysfunction | regulates | mechanism | 0.85 |
| BRAIN TUMOURS | associated_with | entity | 0.85 |
| Telomere Maintenance | involved_in | process | 0.85 |
| Tumor | activates | disease | 0.85 |
| NASH-Related Hepatocellular Carcinoma | biomarker_for | disease | 0.80 |
| MAPK1 | activates | gene | 0.80 |
| Telomere Dysfunction | involved_in | process | 0.80 |
| Oxidative Stress | activates | pathway | 0.80 |
| GENES | associated_with | gene | 0.80 |
| OXIDATIVE STRESS | activates | gene | 0.80 |
| Fibrosis | activates | disease | 0.75 |
| Als | activates | disease | 0.75 |
| Aging | activates | disease | 0.75 |
| Senescence | activates | disease | 0.75 |
| Als | associated_with | disease | 0.75 |
| Glioblastoma | activates | disease | 0.75 |
| Als | therapeutic_target | disease | 0.75 |
| Carcinoma | therapeutic_target | disease | 0.75 |
| Cancer | therapeutic_target | disease | 0.75 |
| Cancer | activates | disease | 0.75 |
| Cancer | associated_with | disease | 0.75 |
| CANCER | activates | gene | 0.70 |
| Wnt | therapeutic_target | pathway | 0.70 |
| SMARCA4 | therapeutic_target | gene | 0.70 |
| SENESCENCE | protects_against | phenotype | 0.70 |
| Tgf-Β | activates | pathway | 0.70 |
| telomere synthesis | activates | process | 0.70 |
| NRF2 | inhibits | gene | 0.70 |
| CDKN2A | associated_with | gene | 0.70 |
| cellular senescence | protects_against | process | 0.70 |
| Apoptosis | activates | pathway | 0.70 |
| GENES | therapeutic_target | gene | 0.70 |
| TP53 | activates | gene | 0.70 |
| EGFR | activates | gene | 0.70 |
| Epigenetic | contributes_to | pathway | 0.70 |
| Nf-Κb | activates | pathway | 0.70 |
| aging | regulates | process | 0.70 |
| Ataxia | expressed_in | disease | 0.65 |
| Aging | contributes_to | disease | 0.65 |
| Schizophrenia | expressed_in | disease | 0.65 |
| Cancer | regulates | disease | 0.65 |
| Carcinoma | associated_with | disease | 0.65 |
| Glioma | biomarker_for | disease | 0.65 |
| Inflammation | associated_with | disease | 0.65 |
| Senescence | associated_with | disease | 0.65 |
| Tumor | expressed_in | disease | 0.65 |
| Senescence | expressed_in | disease | 0.65 |
| Als | expressed_in | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| GABPB1 | activates | gene | 0.90 |
| VEGFA | therapeutic_target | gene | 0.70 |
| MEK/ERK/AP-1 | regulates | pathway | 0.70 |
| TAC | activates | drug | 0.70 |
| LZTR1 | inhibits | gene | 0.60 |
| RNA | inhibits | gene | 0.60 |
| CCND1 | targets | gene | 0.60 |
| CTLA4 | targets | gene | 0.60 |
| EOMES | targets | gene | 0.60 |
| BRG1 | therapeutic_target | gene | 0.60 |
| EP300 | therapeutic_target | gene | 0.60 |
| CTNNB1 | therapeutic_target | gene | 0.60 |
| FOXM1 | therapeutic_target | gene | 0.60 |
| GJA1 | regulates | gene | 0.60 |
| ACVR2A | activates | gene | 0.60 |
| CTNNB1 | activates | gene | 0.60 |
| CD38 | therapeutic_target | gene | 0.60 |
| SRC | activates | gene | 0.60 |
| STAT3 | activates | gene | 0.60 |
| ERK1 | activates | gene | 0.60 |
| CREBBP | therapeutic_target | gene | 0.60 |
| GAIN | therapeutic_target | gene | 0.60 |
| CANCER | biomarker_for | gene | 0.60 |
| WNT | inhibits | gene | 0.60 |
| GENES | associated_with | gene | 0.60 |
| PD-L1 | inhibits | gene | 0.60 |
| PINK1 | activates | gene | 0.60 |
| ATF3 | targets | gene | 0.60 |
| AXIN2 | targets | gene | 0.60 |
| DKK1 | targets | gene | 0.60 |
| FZD7 | targets | gene | 0.60 |
| PPARD | targets | gene | 0.60 |
| PTGS2 | targets | gene | 0.60 |
| SNAI1 | targets | gene | 0.60 |
| AKT3 | activates | gene | 0.60 |
| CDKN2A | activates | gene | 0.60 |
| MDM4 | activates | gene | 0.60 |
| PDGFRA | activates | gene | 0.60 |
| PTEN | activates | gene | 0.60 |
| AGING | therapeutic_target | gene | 0.60 |
| MITOCHONDRIAL DYSFUNCTION | therapeutic_target | gene | 0.60 |
| CANCER | therapeutic_target | gene | 0.60 |
| CDH1 | therapeutic_target | gene | 0.60 |
| INFLAMMATION | therapeutic_target | gene | 0.60 |
| ANTIOXIDANT GENES | therapeutic_target | gene | 0.60 |
| AGING | contributes_to | gene | 0.60 |
| CANCER | contributes_to | gene | 0.60 |
| MICRORNAS | interacts_with | gene | 0.60 |
| NF-ΚB | activates | gene | 0.60 |
| NF-ΚB | interacts_with | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning TERT in their description or question text
No additional research found